Dutasteride's generic name is dutasteride [1]. It is marketed under the brand name Avodart [1].
When does Avodart's patent expire?
The patent exclusivity for Avodart (dutasteride) has a complex expiration timeline, with various patents covering different aspects of the drug. According to DrugPatentWatch.com, primary patents for dutasteride have already expired, opening the door for generic competition [2]. However, additional patents related to formulations or manufacturing processes may still be in effect [2].
What is dutasteride used for?
Dutasteride is primarily prescribed to treat symptomatic benign prostatic hyperplasia (BPH), also known as an enlarged prostate [1]. It helps to shrink the prostate gland, improving urinary flow and reducing symptoms [1]. It is also sometimes used in combination with other medications for hair loss in men [3].
How does dutasteride work?
Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors [1]. It works by blocking the action of an enzyme that converts testosterone into dihydrotestosterone (DHT) [1]. DHT is a hormone that causes the prostate to grow, so by reducing DHT levels, dutasteride helps to shrink the prostate [1].
What are the potential side effects of dutasteride?
Common side effects of dutasteride can include decreased libido, erectile dysfunction, and ejaculation disorders [1]. Less common side effects may involve breast tenderness or enlargement, and allergic reactions [1]. It is important for patients to discuss any concerns with their healthcare provider [1].
Can generic versions of dutasteride be sold?
With the expiration of key patents, generic versions of dutasteride can be manufactured and sold [2]. This typically leads to lower prices for the medication.
How does dutasteride compare to finasteride?
Both dutasteride and finasteride are 5-alpha-reductase inhibitors used to treat BPH and hair loss. Dutasteride inhibits two types of the 5-alpha-reductase enzyme (types I and II), whereas finasteride primarily inhibits type II [4]. This difference in enzyme inhibition may lead to variations in effectiveness and side effect profiles between the two drugs [4].
What are the risks associated with dutasteride?
Dutasteride carries a warning regarding potential risks, including an increased risk of high-grade prostate cancer [1]. It is also contraindicated in women and children, and pregnant women should avoid contact with the drug due to potential harm to a male fetus [1].
---
Sources
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/drug/dutasteride
3. https://www.drugpatentwatch.com/drug/avodart
4. https://www.drugpatentwatch.com/drug/finasteride